Compare AKRO & CSW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AKRO | CSW |
|---|---|---|
| Founded | 2017 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Home Furnishings |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.5B | 4.4B |
| IPO Year | 2019 | N/A |
| Metric | AKRO | CSW |
|---|---|---|
| Price | $54.65 | $305.60 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 11 | 4 |
| Target Price | $73.56 | ★ $309.25 |
| AVG Volume (30 Days) | ★ 2.4M | 190.5K |
| Earning Date | 11-07-2025 | 01-29-2026 |
| Dividend Yield | N/A | ★ 0.35% |
| EPS Growth | N/A | ★ 15.78 |
| EPS | N/A | ★ 8.52 |
| Revenue | N/A | ★ $964,795,000.00 |
| Revenue This Year | N/A | $22.62 |
| Revenue Next Year | N/A | $12.16 |
| P/E Ratio | ★ N/A | $35.83 |
| Revenue Growth | N/A | ★ 14.87 |
| 52 Week Low | $21.34 | $230.45 |
| 52 Week High | $58.40 | $401.02 |
| Indicator | AKRO | CSW |
|---|---|---|
| Relative Strength Index (RSI) | 68.63 | 62.85 |
| Support Level | $54.30 | $282.16 |
| Resistance Level | $54.70 | $317.50 |
| Average True Range (ATR) | 0.17 | 11.83 |
| MACD | -0.10 | -0.50 |
| Stochastic Oscillator | 71.07 | 58.40 |
Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis (MASH), or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that have the potential to address the core processes underlying NASH pathogenesis.
CSW Industrials Inc is a diversified industrial growth company with well-established, scalable platforms and domain expertise across three segments, Contractor Solutions, Engineered Building Solutions, and Specialized Reliability Solutions. The company's Contractor Solutions segment involves manufacturing efficient and performance-enhancing products for residential and commercial HVAC/R and plumbing applications, which are designed for professional end-use customers. Majority of the company revenue is generated from Contractor Solutions segment from U.S. markets.